The results feed into an effort to identify to monoclonal antibody combinations that would prevent and possibly treat HIV ...

Breakthrough nanovaccine uses tumor cell membranes and immune-boosting polymers to enhance personalized cancer immunotherapy, ...

IntegriMedical has introduced a needle-free injection system (N-FIS) that eliminates the need for any prick or piercing, ...

Arguably the most notable of the FDA’s upcoming decisions is that regarding Gilead’s twice-yearly HIV prophylaxis lenacapavir ...

For the first time in Canada, a patient has received cancer immunotherapy by subcutaneous (under the skin) injection in their home, thanks to an innovative research initiative by Horizon Health ...

TARRYTOWN, N.Y. and PARIS, June 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: REGN) and Sanofi today presented results from the DISCOVER Phase 4, single-arm, open-label trial assessing Dupixent ® (dupilumab) ...

Funding expected to support operations into Q1 2026. Anticipated AMPLIFY-7P Phase 2 interim analysis expected in Q3 2025. BOSTON, Ju ...

Most subcutaneous and intramuscular injections cause only mild pain. Some vaccines can leave the area sore for a day or two; this is a normal part of your immune system’s response. It’s also common to ...

Combination vaccines are recommended by health authorities worldwide to reduce the number of jabs given to children while ...

When it comes to vaccines, where they go into your body can make a surprising difference in how well they work. Scientists in ...

Scientists in the U.S. have developed polymer microparticles that can release vaccines at specific times after injection, sometimes even months later, potentially removing the need for multiple ...